Evidence map›Paper›PMID 32170024›Full record

ArticleJournal of lipid research2020

Myeloid-specific deficiency of pregnane X receptor decreases atherosclerosis in LDL receptor-deficient mice.

Yipeng Sui, Zhaojie Meng, Se-Hyung Park, Weiwei Lu, Christopher Livelo, Qi Chen, Tong Zhou, Changcheng Zhou

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Physiological Functions and Pathological Roles of PXR.Journal of the Endocrine Society · 2025
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Adipocyte-Derived PXR Signaling Is Dispensable for Diet-Induced Obesity and Metabolic Disorders in Mice.Drug metabolism and disposition: the biological fate of chemicals · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Yipeng SuiDepartment of Pharmacology and Nutritional Sciences,University of Kentucky, Lexington, KY 40536.
Zhaojie MengDepartment of Pharmacology and Nutritional Sciences,University of Kentucky, Lexington, KY 40536; Division of Biomedical Sciences, School of Medicine, University of California, Riverside, CA 92521.
Se-Hyung ParkDepartment of Pharmacology and Nutritional Sciences,University of Kentucky, Lexington, KY 40536.
Weiwei LuDepartment of Pharmacology and Nutritional Sciences,University of Kentucky, Lexington, KY 40536.
Christopher LiveloDivision of Biomedical Sciences, School of Medicine, University of California, Riverside, CA 92521.
Qi ChenDivision of Biomedical Sciences, School of Medicine, University of California, Riverside, CA 92521.
Tong ZhouDepartment of Physiology and Cell Biology, Reno School of Medicine, University of Nevada, Reno, NV 89557.
Changcheng ZhouDepartment of Pharmacology and Nutritional Sciences,University of Kentucky, Lexington, KY 40536; Division of Biomedical Sciences, School of Medicine, University of California, Riverside, CA 92521. Electronic address: mailto:changcheng.zhou@ucr.edu.
University of Kentucky · USUniversity of California, Riverside · USUniversity of Nevada, Reno · US

Funding

Pilot Projects ProgramP30GM127211 · NIGMS · UNIVERSITY OF KENTUCKY · PI CASSIS, LISA A · 2018 to 2022
$5.7M
Endocrine disruptor mediated activation of PXR causes dyslipidemia and atherosclerosisR01ES023470 · NIEHS · UNIVERSITY OF KENTUCKY · PI ZHOU, CHANGCHENG · 2013 to 2022
$2.7M
Role of IKKβ in obesity and atherosclerosisR01HL131925 · NHLBI · UNIVERSITY OF KENTUCKY · PI ZHOU, CHANGCHENG · 2016 to 2019
$1.5M
A novel mechanism for ART-associated dyslipidemia and atherosclerosisR01HL123358 · NHLBI · UNIVERSITY OF KENTUCKY · PI ZHOU, CHANGCHENG · 2015 to 2018
$1.5M
NHLBI NIH HHS R01 HL123358NHLBI NIH HHS R01 HL131925NIEHS NIH HHS R01 ES023470NIGMS NIH HHS P30 GM127211
6 · The paper itself

Abstract

The pregnane X receptor (PXR) is a nuclear receptor that can be activated by numerous drugs and xenobiotic chemicals. PXR thereby functions as a xenobiotic sensor to coordinately regulate host responses to xenobiotics by transcriptionally regulating many genes involved in xenobiotic metabolism. We have previously reported that PXR has pro-atherogenic effects in animal models, but how PXR contributes to atherosclerosis development in different tissues or cell types remains elusive. In this study, we generated an LDL receptor-deficient mouse model with myeloid-specific PXR deficiency (PXR

Indexed as

AnimalsAtherosclerosisCD36 AntigensFoam CellsGene Expression RegulationLipidsMacrophagesMicePhenotypePregnane X ReceptorReceptors, LDLCD36 AntigensLipidsPregnane X ReceptorReceptors, LDLcardiovascular diseasecluster of differentiation 36foam cellslipid homeostasislipidslow density lipoproteinmacrophagestranscriptomexenobiotic sensor

Identifiers

PMID32170024
PMCPMC7193955
OpenAlexW3011087034

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.